Corporate
Triple Hair Group announces strategic arrangement with leading US compounding company Pharmacy Solutions
Triple Hair Group Inc. (“Triple Hair” or the “Company”), a company specializing in the development of innovative treatments for alopecia, is pleased to announce that it has entered into a strategic licensing agreement with Pharmacy Solutions to compound Triple Hair’s hair growth products in the United States. Alopecia is an under-served global market of USD 7.8 billion in 2021, estimated to reach USD 14.2 billion in 2028.
Triple Hair Group announces strategic arrangement with leading US compounding company Pharmacy Solutions

“This is truly game-changing for Triple Hair, to have Pharmacy Solutions as a strategic partner for the development and sales of our hair growth products in the US,” said Jean-Philippe Gravel, President and CEO of Triple Hair. “This agreement has multiple benefits. It allows us to offer our patented triple combination hair growth product and our two over-the-counter brands, RIZN and Plenty Natural, available to hair loss sufferers across the US. Pharmacy Solutions is a leader in compounding and delivery of pharmaceutical products.”

“We are very pleased to partner with Triple Hair, whose hair growth products fit perfectly with our business model and expertise,” said Kim Siegenthaler, Director of Business Development at Pharmacy Solutions. “They help fill a critical need and address a very large potential market. We are excited to enter into this partnership with Triple Hair and the opportunity to offer its products within the US.”
 
The patented triple combination hair growth product is the first product of its kind to combine 3 proven ingredients for the treatment of androgenic alopecia on the market.

About Triple Hair
 
Triple Hair Group Inc. is a Canadian biotechnology company specializing in developing innovative treatments for men and women suffering from alopecia. Its mission is to provide the under-served market with clinically proven and efficient prescription and over-the-counter treatments for hair regrowth.
 
Triple Hair’s patented Triple Combination Hair Growth Therapy (therapy-07 prescription drug) is known to be the most promising and the first product of its kind for the treatment of androgenic alopecia. This clinical-stage therapy is made of an optimal fixed-dose combination of 3 safe and approved ingredients, proven to be effective in inducing new hair regrowth in different stages of androgenic alopecia.
 
The Company also sells its drug-free patented products for preventing hair loss and regaining hair density in mild to moderate cases of alopecia under the brands RIZNTM (www.rizn.ca) for men, and Plenty NaturalTM (www.plentynatural.ca) for women. RIZNTM and Plenty NaturalTM allow hair loss sufferers in their early stages to access effective and natural hair growth solutions without a prescription easily.
 
For more information, visit the Company’s website, at www.triplehair.ca.